Theravance To Split To Create Firm Focused On GSK Tie-Up
Biopharmaceutical firm Theravance Inc. will be split into two independent publicly traded firms, one of which will work with British pharmaceutical giant GlaxoSmithKline PLC on their ongoing collaboration to develop certain...To view the full article, register now.
Already a subscriber? Click here to view full article